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Abstract
Background: Central venous catheters (CVC) are needed for monitoring and treatment of criti-
cally ill patients; however, their use increases the risk of bacteremia. The aim of the study was 
to quantify the incidence of central venous catheter-related bacteremia (CVCRB) and to identify 
factors associated with this infection.
Methods: A prospective cohort study was conducted in a concentration hospital of western 
Mexico. The association of CVCRB and study variables was investigated using multivariate Cox 
regression analysis.
Results: Two hundred and four patients with CVC were studied. The mean age was 4.6 years; 
66.2% were male. Insertion sites of the catheters were subclavian vein 72.5% (n = 148), jugular 
vein 20.1% (n = 41) and femoral vein 7.4% (n = 15). CVCRB incidence was 6.5 events/1,000 cathe-
ter-days; microorganisms identified were gram-positive cocci 37.5% (n = 6), gram-negative ba-
cilli 37.5% (n = 6) and Candida albicans 25% (n = 4). It was observed that the increase in catheter 
manipulations per day was associated with bacteremia (HR 1.14, 95% CI 1.06-1.23), whereas the 
use of intravenous antibiotics showed a protective effect (HR 0.84, 95% CI 0.76-0.92).
Conclusions: In addition to the strategies of maximum caution when placing or manipulating the 
catheter, we recommend decreasing, as much as possible, disconnects between the CVC and 
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1. Introduction
Central venous catheters (CVC) are needed for monitoring 
and treatment of critically ill patients; however, their use 
increases the risk of bacteremia (OR 4.51 95% CI 2.49-8.18, p 
< 0.001).1-4 The presence of intravascular devices has been 
the main cause of hospital bloodstream infections, with a 
mortality rate of 25%.5-11
Microbial flora of the skin migrates through both outer 
and inner surfaces of the catheter or enters the bloodstream 
through contaminated solutions. In short-term intravascular 
devices, most central venous catheter-related bloodstream 
infections (CVCRB) are originated by the colonization of the 
outer surface, while in the long-term catheters infections 
occur mainly by contamination of the inner surface.9,12-14
An hour after the catheter is colonized, microorganisms 
can be identified 4 cm away from the site of colonization.2,12 
Subsequently, pathogens adhere to the catheter surface and 
form a protective film of extracellular polymers that sur-
rounds bacteria and retains nutrients. Under these condi-
tions, microorganisms may be resistant to antimicrobial 
treatment and phagocytic activity of the immune system.2,15
Clinical diagnosis of CVCRB is not specific. Microbiological 
analyses to confirm infections are performed in only 15 to 
39% of patients with clinical manifestations. Differential 
time to positivity of blood cultures allow greater accuracy in 
diagnosis.6,16,17
Different conditions have been associated with the in-
creased risk of CVCRB: age of the patient (< 10 years), catheter 
insertion without sterile barriers, difficulties during place-
ment, bacterial colonization of the insertion site, placement in 
the femoral vein, total parenteral nutrition, blood transfusions 
and duration of catheter placement > 7 days.7,10,11,14,18-23 Since 
strategic planning for prevention requires understanding the 
epidemiology of the CVCRB, the objective of this study was to 
quantify the incidence of CVCRB and to identify the main risk 
factors in a concentration hospital in western Mexico.
2. Patients and methods
A prospective cohort study was conducted in the Nuevo Hos-
pital Civil de Guadalajara Dr. Juan I. Menchaca (HCGJIM) in 
Guadalajara, Jalisco, Mexico, from March 18, 2011 to June 
24, 2012. The study was approved by the Ethics and Re-
search Committees of the institution.
Patients in the pediatric Intensive Care Unit (ICU) and in 
the pediatric Emergency Room (ER) who had a CVC placed 
the infusion line. Antibiotics showed a protective effect, but the outcome is uncertain and the 
promotion of antimicrobial resistance should be considered.
© 2015 Hospital Infantil de México Federico Gómez. Published by Masson Doyma México S.A. 
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Resumen
Introducción. El catéter venoso central (CVC) es necesario para la monitorización y tratamiento 
de pacientes en estado crítico; sin embargo, su uso incrementa el riesgo de bacteriemia. El 
objetivo del estudio fue cuantificar la incidencia de bacteriemia relacionada con catéter venoso 
central (BRCVC) e identificar los factores asociados con esta infección.
Métodos. Se realizó un estudio de cohorte prospectivo en un hospital de concentración del oc-
cidente de México. Para conocer la asociación entre BRCVC y las variables en estudio, se realizó 
un análisis multivariado con regresión de Cox.
Resultados. Se estudiaron 204 pacientes con CVC. La edad promedio fue de 4.6 años; el 66.2% 
fue del sexo masculino. Los sitios de inserción del catéter fueron la vena subclavia (72.5%, n = 
148), la vena yugular (20.1%, n = 41) o la vena femoral (7.4%, n = 15). La incidencia de BRCVC 
fue de 6.5 eventos por 1,000 días catéter. Los microorganismos identificados fueron cocos Gram 
positivos (37.5%, n = 6), bacilos Gram negativos (37.5%, n = 6) y Candida albicans (25%, n = 4). 
Se observó que la mayor manipulación del catéter por día se asoció con bacteriemia (RR 1.14, 
IC95% 1.06-1.23), mientras que el uso de antibióticos intravenosos mostró un efecto protector 
(RR 0.84, IC95% 0.76-0.92).
Conclusiones. Además de las medidas máximas de precaución al momento de colocar o mani-
pular el catéter, es conveniente disminuir lo más posible las desconexiones entre el equipo de 
venoclisis y el CVC. Los antibióticos mostraron un efecto protector; sin embargo, se debe consi-
derar el riesgo de favorecer resistencias antimicrobianas.
© 2015 Hospital Infantil de México Federico Gómez. Publicado por Masson Doyma México S.A. 
Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/ 
licenses/by-nc-nd/4.0/).
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and had no bloodstream infection at the time of placing en-
tered the cohort. Although patients were transferred to an-
other department of the HCGJIM, their surveillance 
continued. Exclusion criteria were patients who died, who 
had catheter removal, those who presented bloodstream in-
fection or were transferred to another hospital. Aseptic 
technique with povidone-iodine was performed prior the 
insertion of the intravascular catheter as well as a thorough 
washing of hands of the medical personnel; maximum ster-
ile barriers (gloves, gown, cap and mask) were used during 
the procedure.24
2.1. Variables
Data from the cohort of patients, such as age, sex, diagno-
sis, anatomical region where the catheter was placed, type 
of catheter and complications during insertion were regis-
tered from the clinical files. The use of mechanical ventila-
tion, total parenteral nutrition, antibiotics and transfusions 
were monitored daily. The number of manipulations of the 
catheter was quantified in nursing records. Any procedure 
requiring disconnection of both CVC and venoclysis equip-
ment was defined as manipulation of the catheter.
2.2. Sampling procedure
At least two samples for blood cultures were collected from 
patients who had clinical manifestations suggestive of infec-
tion related to the catheter (fever, hypothermia, tachycar-
dia, bradycardia, leukocytosis, leukopenia, erythema or 
secretion from the catheter entry site): one through the CVC 
and the other from a peripheral vein. In each Pediatric FAN 
BacT/ALERT® PF (bioMérieux) bottle, ≥ 2 ml of blood were 
inoculated. Before sampling, aseptic techniques were con-
ducted with povidone-iodine at the puncture site and into 
the lumen of the catheter entry. Similar amounts of blood 
were inoculated in each blood culture bottle.25
Cultures were incubated in the automatic system of de-
tection of microbial growth BacT/ALERT® 3D (bioMérieux). 
In case of bacterial growth, the system recorded the time of 
detection of positivity. Positive cultures were reseeded in 
blood and MacConkey’s agars. Identification of bacterial 
species was carried out in the MicroScan autoSCAN-4 Sys-
tem® (Beckman Coulter, Inc.). Cultures without growth 
were monitored for 7 days prior to classify them as negative.
CVCRB diagnosis was established when both blood cul-
tures (catheter and peripheral) presented growth of the 
same microorganism, and if the blood culture of the cathe-
ter occurred before with a difference of time detection of 
positivity ≥ 2 h. If both cultures were positive to the same 
germ but with a time of positivity < 2 h, or if only the pe-
ripheral culture was positive, it was classified as non-cathe-
ter-related bloodstream infection. If only the culture 
collected from CVC presented growth, it was diagnosed as 
colonization of the catheter.
2.3. Statistical analysis
Incidence density of CVCRB was estimated with 95% confi-
dence intervals (95% CI). For quantitative variables, means 
and standard deviations (SD) were calculated; qualitative 
variables were presented as frequencies and percentages. 
To evaluate the association between quantitative variables 
and CVCRB (bivariate analysis), Cox proportional risk model 
was used. For qualitative variables, hazard risk (HR) with 
95% CI was estimated. Variables that showed a value of p ≤ 
0.2 were included in multivariate Cox regression analysis. 
Information was analyzed using the statistical program IBM-
SPSS Statistics v. 20.
3. Results
We studied 204 patients with CVC. The mean age was 4.6 
years (minimum 0.08, maximum 16, SD 5.17), and 66.2% (n = 
135) were male. Most frequent diagnoses (ICD-10) were neo-
plasms (28.9%, n = 59), infectious diseases other than blood-
stream infections (19.6%, n = 40), central nervous system 
diseases (15.2%, n = 31) and genitourinary system diseases 
(5.9%, n = 12).
Insertion of the catheter was performed in the subclavian 
vein (72.5%, n = 148), jugular vein (20.1%, n = 41) or femoral 
vein (7.4%, n = 15), from which 80.4% (n = 164) was with a 
multi-lumen catheter. Three patients presented immediate 
complications after placement. The average of catheter-
days by patient was 11.2 (minimum 1, maximum 58, SD 8.9) 
and the average hospital stay at the moment of placing the 
catheter was 7.5 days (minimum 0, maximum143, SD 17.2).
The catheters studied (n = 204) accumulated 2,294 cath-
eter-days. Fifteen CVCRB events, nine non-catheter-related 
bloodstream infections and 20 colonized catheters were 
identified. The incidence density of CVCRB was 6.5 events 
per 1,000 days (95% CI 3.8-10.5).
Patients without CVCRB (n = 189) discontinued the study 
for the following reasons: catheter removal (71.4%, n = 135), 
death (22.8%, n = 43), transfer to another hospital unit (1%, 
n = 2) or non-catheter-related bloodstream infections (4.8%, 
n = 9).
Microorganisms isolated (n = 16) were coagulase-negative 
staphylococci (n = 5), Candida albicans (n = 4), Enterobacter 
cloacae (n = 2), Staphylococcus aureus (n = 1) and other 
gram-negative bacilli with one isolation each (Escherichia 
coli, Acinetobacter baumannii, Serratia marcescens, Steno-
trophomonas maltophilia). In one same event, two bacteria 
were isolated (Escherichia coli and Enterobacter cloacae).
Incidence of CVCRB in function of the qualitative varia-
bles, HR and 95% CI, are listed in table 1. Mean and SD of 
quantitative variables and bivariate analysis with CVCRB are 
shown in table 2. There were no significant differences in 
the permanence of the catheter in patients with or without 
CVCRB (p < 0.56).
Variables with a value of p ≤ 0.2 were included in the 
multivariate analysis, and non-significant variables were ex-
cluded step by step. The final model was integrated with 
the following variables: days of administration of antibiotics 
and average manipulations per day (Table 3).
4. Discussion
In 2012, information from the National Healthcare Safety 
Network (NHSN) indicated that, in not cancer pediatric care 
departments, CVCRB rate was quantified from 0.5 to 1.4 
events per 1,000 catheter-days. The highest frequency was 
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observed in the areas of surgery and surgical cardiology. 
Patients of cancer services have reported a frequency of 2.3 
CVCRB events per 1,000 patient-days.26 In this study, the in-
cidence of CVCRB was 6.5 events by 1,000 catheter-days, 
and in patients with oncological diseases, 9.07 events for 
1,000 days. Both frequencies were higher than those report-
ed by the NHSN. It has been identified that intravascular 
devices placed in ICUs are more likely to be associated with 
bloodstream infections.18 Abramczyk et al., in São Paulo 
Hospital, University of São Paulo, quantified an incidence of 
10.2 CVCRB events for 1,000 catheter in children in an ICU.27
With regard to the etiologic agents of CVCRB in patients 
of the HCGJIM, a high frequency of isolates of gram-negative 
bacilli was observed. This condition is probably associated 
with external contamination and not with commensal skin 
bacteria, which are the most frequently reported in various 
studies.9,12 Safdar and Maki described that 45% of CVCRB are 
caused by external colonization of the catheter,9 while Gar-
Table 1 Incidence density of central venous catheter-related bloodstream infection based on qualitative variables
Events Catheter-days ID x 1,000 
catheter-days
HR 95% CI p
Gender
Male 7 1,572 4.5 1
Female 8 722 11.1 2.49 0.90-6.86 0.06
Infections other than bacteremia
Absent 14 1,926 7.3 1
Present 1 368 2.7 0.37 0.05-2.84 0.56
Oncological diseases
Absent 11 1,853 5.94 1
Present 4 441 9.07 1.53 0.49-4.80 0.64
Insertion site
Subclavian vein 9 1,704 5.28 1
Jugular vein 3 397 7.56 1.43 0.38-5.2 0.80
Femoral vein 3 193 15.5 2.94 0.80-10.8 0.23
Multi-lumen catheter
Absent 2 465 4.3 1
Present 13 1,829 7.1 1.65 0.37-7.32 0.77
Mechanical ventilation
Absent 4 875 4.6 1
Present 11 1,419 7.8 1.70 0.54-5.32 0.52
Use of antibiotics
Absent 1 156 6.4 1
Present 14 2,138 6.5 1.02 0.13-7.77 0.99
Parenteral nutrition
Absent 3 904 3.3 1
Present 12 1,390 8.6 2.60 0.73-9.22 0.19
Administration of hemoderivatives
Absent 4 566 7.0 1
Present 11 1,728 6.4 0.90 0.29-2.82 0.99
ID: Incidence density; HR: hazard risk; 95% CI: 95% confidence interval.
Table 2 Bivariate analysis of quantitative variables and CVCRB
Variable Mean SD HR 95% CI p
Age 4.6 5.2 0.99 0.90-1.09 0.86
Stay prior to the insertion of CVC (days) 7.5 17.2 0.99 0.96-1.02 0.55
Mechanical ventilation (days) 3.6 5.2 0.94 0.87-1.03 0.25
Antibiotics (days) 9.2 8.7 0.89 0.83-0.97 0.008
Parental nutrition (days) 4.1 9.2 1.01 0.97-1.05 0.67
Manipulations per day 15.1 7.9 1.10 1.02-1.18 0.01
Amount of blood products 2.5 4.7 1.01 0.94-1.08 0.69
SD: standard deviation; HR: hazard risk; 95% CI: 95% confidence interval; CVC: central venous catheter.
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land et al. identified that 67% (n = 10) of CVCRB events were 
secondary to an inner lumen colonization in newborn pa-
tients.12 In both studies, the most frequently isolated bacte-
ria were coagulase-negative staphylococci (77.1% and 93.3%, 
respectively). Hammarskjöld et al. quantified an incidence 
of catheter colonization of 7.6 events for 1,000 days. The 
predominant bacteria were coagulase-negative staphylococ-
ci (60%), and the duration of catheterization showed a ten-
dency to increase the probability of colonization (HR 1.009, 
95% CI 1.003-1.015).3 In the present cohort, the estimated 
incidence of colonization was 8.7 events per 1,000 catheter-
days, and 75% of bacteria were Staphylococcus sp. Although 
it has been proposed that catheter colonization may pre-
cede infections, this condition is not a specific predictor of 
bloodstream infections. Koh et al. noted that only 5.8% of 
arterial lines and 7.5% of colonized venous lines developed 
CVCRB. No differences in the frequency of colonization be-
tween both types of vascular lines were identified (HR 1.17, 
95% CI 0.41-3.36), and catheters placed in an ER showed an 
increased risk (HR 4.45, 95% CI 1.42-13.9).8
In this study, it was noted that the increase of catheter 
manipulations per day relates to bloodstream infections (HR 
1.14, 95% CI 1.06-1.23) while the use of intravenous antibiot-
ics showed a protective effect (HR 0.84, 95% CI 0.92-0.76). 
Some previously described risk factors for CVCRB (< 10 years 
of age, difficulties during insertion, parenteral nutrition, 
mechanical ventilation, transfusions, multiple lumen cathe-
ters or femoral vein placement)7,19,21 showed no significant 
association. However, this result may be due to the sample 
size. Mahieu et al. studied the influence of different forms 
of catheter manipulation on the frequency of CVCRB. Dis-
connection of the catheter for disinfection of the hub (OR 
1.2, 95 CI 1.1-1.3%) and blood sampling (OR 1.4, 95% CI 1.1-
1.8) increased the risk of bloodstream infections, while hep-
arinization (OR 0.9, 95% CI 0.8-1.0) and exit site antisepsis 
(OR 0.9, 95 CI% 0.8-1.0) showed a protective effect.13
In addition to hand washing and the use of maximum 
sterile barriers when inserting the catheter,12,24 it is suggest-
ed to reduce as much as possible disconnects between the 
venoclysis equipment and CVC. The lowest number of medi-
cation doses should be administered per day; intravenous 
solutions should be prepared every 24 h instead of every 8 h, 
and the use of infusion pumps28 is recommended, especially 
for drugs that require frequent dose changes.
In a similar study of cases and controls, Vilela et al. ob-
served that the concomitant use of antibiotics in patients 
with CVC decreased the risk of infection (OR 0.06, 95% CI 
0.016-0.29).20 However, the protective effect of antimicrobi-
als is uncertain due to the possibility of false-negative results 
of blood cultures if the samples were obtained when antibiot-
ics were being administered. The risk of antimicrobial resist-
ance of microorganisms attached to catheters and protected 
by extracellular polysaccharides should also be considered.
According to the NHSN, an increased frequency of infec-
tions related to CVC is present in school hospitals.26 There-
fore, in these hospitals, preventive measures should be 
strengthen, including the appropriate training for the cor-
rect insertion and maintenance of the catheter, the moni-
toring of infection rates, hand hygiene, the use of infusion 
solutions equipment, the use of sterile gloves for manipula-
tion of the intravenous lines, and the withdrawal of the 
catheter as soon as possible.6,29
A limitation of this study was the sample size, which may 
explain the absence of the association between the varia-
bles described as risk factors and the CVCRB. The protective 
effect of antibiotics for CVCRB should be assessed through 
diagnostic tests other than blood cultures due to the possi-
bility of false-negative results.
Finally, it is suggested to decrease as much as possible 
disconnects between the line of infusion and CVC. Strate-
gies to achieve this include administering medications with 
the lowest number of possible doses, indicate 24 h solution 
infusions and the use of continuous infusion pumps. Al-
though antibiotics have a protective effect for CVCRB, its 
indication is not recommended until the impact on antimi-
crobial resistance is assessed.
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Table 3 Variables associated with central venous catheter-related bloodstream infection identified with multivariate analysis 
using Cox regression
HR 95% CI Exp (B) p
Lower Upper
Manipulations per day 1.14 1.06 1.23 < 0.001
Antibiotics (days) 0.84 0.76 0.92 0.001
HR: hazard risk; 95% CI: 95% confidence interval.
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